Validation of Digital Chest-X-ray (CXR) to Assess Lung Recruitment in ARDS
NCT ID: NCT02081105
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
38 participants
INTERVENTIONAL
2014-02-28
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative Computed Tomography for Mortality Risk Stratification in ARDS
NCT06113276
Early PP Monitored by EIT in Patients With ARDS
NCT05822869
Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome
NCT04012073
A Comparison of Optimal PEEP Determination Guided by EIT and Conventional Protective Ventilation Tool in ARDS Patients
NCT03498807
Post- End- Expiratory Pressure Affect the Alveolar Heterogeneity in Moderate and Sever ARDS Patients
NCT03763890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PEEP 5
level of PEEP of 5 cm H2O randomly applied to the patient
PEEP of 5 or 15 cm H2O
PEEP of 5 or 15 cm H2O set at the respirator and applied to the patient for 10 minutes. Then, measurements are made at each PEEP in the following order: arterial blood gas, CXR, pressure-volume curve.
PEEP 15
level of PEEP of 15 cm H2O randomly applied to the patient
PEEP of 5 or 15 cm H2O
PEEP of 5 or 15 cm H2O set at the respirator and applied to the patient for 10 minutes. Then, measurements are made at each PEEP in the following order: arterial blood gas, CXR, pressure-volume curve.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PEEP of 5 or 15 cm H2O
PEEP of 5 or 15 cm H2O set at the respirator and applied to the patient for 10 minutes. Then, measurements are made at each PEEP in the following order: arterial blood gas, CXR, pressure-volume curve.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ramsay score 6 under sedation and analgesia
* ICU respirator implemented with pressure-volume curve device
* age equal to or greater than 18 years
* ARDS defined from the Berlin criteria
* absence of pneumothorax on the CXR before the study
* Absence of pleural effusion greater than 500 ml estimated from ultrasonography.
* no child-bearing woman
* written inform consent signed by the next of kin
Exclusion Criteria
* Pleural effusion greater than 500 ml estimated from ultrasonography
* Thoracic surgery in the last 3 months
* Contra-indication to CXR
* contra-indication to PEEP of 15 cm H2O
* contra-indication to PEEP of 15 or PEEP 15 mandated
* pressure-volume curve not feasible
* refusal to participate
* language barrier of the next of kin
* child-bearing woman
* person under legal protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hodane Yonis, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Réanimation Médicale, Hôpital Croix-Rousse, Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013.818
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.